NASDAQ
14.62USD
+0.29 (+2.02%)
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Latest scored catalyst for DRTS: .
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Market cap
1.3B
P/E
—
EPS
—
Beta
1.19
52W range
3.35-15.1
Day range
14.32–15.07
Open
14.90
Prev close
14.33
Volume
629.4K
Avg volume
827.6K
Dividend
0.00
IPO
2021-03-08
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors and human-derived tumors. The company is headquartered in Jerusalem, Israel.
Daily OHLCV with SMA overlays and session pivots. Draw your levels and trendlines on it, or ask the AI analyst what the price is reacting to.
Suppliers, customers, partners and competitors, derived from what the news actually says about Alpha Tau Medical Ltd — not a sector bucket. Click an edge to see the articles that established the link.
